#LiverTwitter Prognostic performance of non-invasive tests #NITs for portal hypertension #CSPH yield similar prognostic information as measurement of hepatic venous pressure gradient #HVPG sciencedirect.com/science/articl…

🌶️ Elastography needed for diagnosing cACLD & CSPH? 🌶️ 👉 Forget the surrogate fibrosis, think of 👪 & their risk 👉 FIB-4 >= 1.75 ~ LSM >= 10kPa by VCTE. Age is no concern! 👉 VITRO >= 2.5 👉 CSPH ruled-in. 👉 🩸-based non-proprietary NIT - same info as LSM! #LiverTwitter 🔗👇

🆕Validation of #Baveno VII criteria & NIT for CSPH in #hepatitis delta ✅NIT identify high-risk HDV-cACLD patients similar to HVPG w/high accuracy 💡NIT may guide novel antiviral treatment prioritization & individualized prognostication 🔗t.ly/c_Bzg #livertwitter

🆕Article in press❕ Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta 🔓#OpenAccess at👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

#twitterliver 👋#PortalHypertension Fans !! Meet the apsiring members 👩‍🔬🧑‍🔬👨‍⚕️👩‍⚕️ of the clinical research group MOTION divided in 8 work packages assigned to their unique expertise...… ⬇️Follow for more insights…⬇️

#LiverTwitter 3 Relay Teams of the Vienna Liver News have finished 🥇🥈🥉 Vienna City Marathon #VCM2024 🏃🏻🏃🏻‍♂️ for #Liver #Disease Awareness

Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… Mathias Jachs Mattias Mandorfer #LiverTwitter

Mathias Jachs & the Non-Invasive CSPH Estimated Risk (NICER) model based on a contemporary cohort integrating SSM-100Hz 👏 👉 Developed in SLD & 🦠 suppression/cure 👉 Improved discrimination & calibration. 👉 It's just the NICER model, I guess! 😜 Thanks The Baveno Cooperation: an EASL Consortium!

Day2️⃣ #Deutsche_Leberstiftung 20. HepNet #MHH Heiner Wedemeyer #MichaelManns Markus Cornberg 🎬 kicking off updates from #EASL EASL Education EASLnews EASL Advocacy 👉🏻🦠 Hepatitis Mathias Jachs 👀 the way to #cure 👉🏻#metabolism Prof. Demir Charité - Universitätsmedizin Berlin curing #firbosis #SLD

Digging up more evidence demonstrating NSBB are 👑 in Hepatology: This Gut Journal study shows that NSBB may reduce systemic inflammation & NSBB-related WBC 📉 is associated with decreased decompensation & 🪦 Mathias Jachs Thomas Reiberger #livertwitter gut.bmj.com/content/70/9/1…

🚨#livertwitter #SpleenStiffness Measurement #SSM by dedicated 100Hz #VCTE #Fibroscan probe improves #PortalHypertension risk assessment 🎯 #NICER model by Mathias Jachs Mattias Mandorfer for the The Baveno Cooperation: an EASL Consortium published The Lancet Gastroenterology & Hepatology 📕t.ly/bL_wv

New research - Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with cACLD thelancet.com/journals/langa… #LiverTwitter The Baveno Cooperation: an EASL Consortium Mattias Mandorfer

Spleen stiffness measurements for prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease - new in The Lancet Gastroenterology & Hepatology A summary👉linkedin.com/posts/rob-brie… #LiverTwitter The Baveno Cooperation: an EASL Consortium Mattias Mandorfer Mathias Jachs

See you there!

A screening #study at #MedUniVienna has shown that the #infection with the #HepatitisDVirus often remained undetected. Seamless testing at #UniversityHospitalVienna increases the diagnosis rate. The results have been published in Scientific Reports! ⬇️ bit.ly/4eRMSXf

🆕 Identification of optimal portal pressure decrease to control #ascites while minimizing HE after #TIPS: A multicenter study 💡60-80% PPG reduction = reduced ascites w/o increased oHE risk! 👥 M. Kabelitz et al in Hepatology 🔗bit.ly/4fYNIlE #livertwitter #liverx

Zwei Forschungsinitiativen der #MedUniWien wurden mit dem „Creating Possible Award“ durch Gilead Sciences Österreich ausgezeichnet ⤵️ 🌟 Wir gratulieren Mathias Jachs und Thomas Szekeres von der MedUni Wien zur Auszeichnung für ihre Forschungsprojekte! ⬇️ bit.ly/3EgUVjJ